MartinSebastianAllen-AuerbachMD

Associate Professor, Molecular & Medical Pharmacology, UCLA School of Medicine

Dr. Allen-Auerbach is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
200 UCLA Medical Plz Ste B114
Los Angeles, CA 90095
Phone+1 310-794-1005

Fax+1 310-267-0227

UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Nuclear Medicine, 2002 - 2003
New York Downtown HospitalResidency, Internal Medicine, 1999 - 2002
University of Vienna Faculty of MedicineClass of 1995

PubMed

242 citations
Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006.
Johannes Czernin, Martin Allen-Auerbach, Heinrich R. Schelbert
Journal of Nuclear Medicine. 2007-01-01
109 citations
Impact of 68Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical Recurrence.
Jeremie Calais, Wolfgang P. Fendler, Matthias Eiber, Jeannine Gartmann, Fang-I Chu
Journal of Nuclear Medicine. 2018-03-01
117 citations
68Ga-PSMA-11 PET/CT interobserver agreement for prostate cancer assessments: an international multicenter prospective study
Wolfgang P. Fendler, Jeremie Calais, Martin Allen-Auerbach, Christina Bluemel, Nina Eberhardt
Journal of Nuclear Medicine. 2017-04-13

UCLA Health Earns Comprehensive Center of Excellence Designation for Radiopharmaceutical Therapy as Work Continues on New FacilityJune 29th, 2022
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical TrialJune 1st, 2019